Target intelligence / Profile preview

Culex pipiens acetylcholinesterase 1 (AChE1)

Target
AChE1
Molecular classification
Enzyme, Hydrolase, Serine esterase, Cholinesterase
01

Overview

Culex pipiens acetylcholinesterase 1 (AChE1), encoded by the ace-1 gene, is a critical enzyme in the nervous system of the common house mosquito. It functions by rapidly hydrolyzing the neurotransmitter acetylcholine at cholinergic synapses, thereby terminating nerve impulses and preventing continuous stimulation of postsynaptic receptors [20, 21]. AChE1 is the primary target for two major classes of synthetic insecticides: organophosphates and carbamates. These compounds covalently bind to the catalytic serine residue, leading to enzyme inhibition, acetylcholine accumulation, and eventual paralysis and death of the insect [2, 9, 10]. The target is of significant public health importance because Culex pipiens serves as a primary vector for several human and animal pathogens, including West Nile virus, St. Louis encephalitis virus, and filarial worms [18, 19]. However, the widespread use of insecticides has led to the emergence of resistance, primarily through target-site mutations such as G119S and F290V, which reduce the enzyme's sensitivity to inhibitors [1, 4, 5]. Current research focuses on developing novel, mosquito-specific inhibitors that target unique structural features, such as the invertebrate-specific Cys286 residue, to improve selectivity and overcome existing resistance mechanisms while minimizing toxicity to non-target organisms like humans [11, 12, 13].

Other names
Acetylcholinesterase 1AChE1ace-1Synaptic acetylcholinesterase
02

Mechanism of action

Inhibition of acetylcholinesterase activity through covalent binding to the catalytic serine residue, leading to acetylcholine accumulation and neuromuscular paralysis.

03

Biological functions

NeurotransmissionTermination of nerve impulsesAcetylcholine hydrolysis
04

Disease associations

West Nile virus infectionSt. Louis encephalitisLymphatic filariasisAvian malaria
05

Safety considerations

Insecticide resistanceCross-reactivity with human acetylcholinesteraseEnvironmental toxicityFitness cost of resistance mutations
06

Interacting drugs

Malathion

8 more in the full profile.

07

Biomarkers

AChE activity levelsG119S mutationF290V mutation

Beyond the preview

Go deeper on Culex pipiens acetylcholinesterase 1 (AChE1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Culex pipiens acetylcholinesterase 1 (AChE1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call